Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

M&A/IPOs

 

Bain and KKR vying for Life’s Max Healthcare stake

Private equity giants Bain Capital and KKR are reportedly fighting it out for South African Life Healthcare's 47.5% stake in Indian hospital chain Max Healthcare. One source tells Healthcare Nova that the rumoured bidders "have no idea what they are buying into".

Turkey’s largest hospital group on the hunt for acquisitions

MLP Care, Turkey's largest hospital group which runs the Medical Park chain, saw substantial revenue and  EBITDA growth in the first six months of the year. Group CFO Burcu Ozturk tells us that is now looking to expand via acquisitions after opening two new hospitals this year.

“No interest” in BMI, propco takeover increasingly likely, say sources

We hear that South African hospital group Netcare has received a less-than-lukewarm reception so far when trying to market its UK asset BMI Healthcare this summer and that a takeover by the propco owners is the most likely scenario, as we reported earlier. But how will the incoming owner return the business to profitability?

Why investors are viewing the UK market with caution

Is the UK is losing out to Europe when it comes to healthcare deals? With so much for sale and so little buying activity recently, Healthcare Europa catches up with a UK market analyst to find out more.

Falck defines core entities and puts Danish clinics into strategic review

Falck, the world's largest emergency services group which had 10.88bn Dkr (€1.45bn) of revenue from ambulances and health services, has defined its core businesses. Two businesses are "undergoing strategic reviews". There are rumours that majority shareholder, Lundbeck Foundation, might sell off the entire group.

Medicover moves into wellness, but reports losses in the UK

Pan- European and Indian healthcare and diagnostics provider Medicover is entering the wellness market, in a move that could provide interesting synergies with its corporate healthcare offering, mainly in Poland and Romania. The company's H1 and second quarter financials show losses in the Indian and UK fertility markets, but strong growth in Eastern Europe. We […]

Find Us